Investment Q&A

Q: Hi, I am a holder and have had the recent pleasure of walking through the Sangoma Proxy materials and have read more about the deal with StarBlue and I'm wondering your thoughts of the transaction, specifically around the details that the StarBlue CEO will be THE major holder of Sangoma (25%). I understand that Sangoma is using their much better capital position to expand and magically double their revenue and garner much more SaaS ARR, however, it feels like the StarBlue organization was far less diligent in their balance sheet management and overall operations. Do you feel the Sangoma management will actually be able to exert their clearly quite strong operational 'chops' on StarBlue? It sort of feels like a reverse buy; As in, StarBlue convinced Sangoma to 'buy' them and thus give them capital, but the actual ownership is with StarBlue.

Q: I would appreciate your comments of the latest acquisition, Vend.
“Vend generated revenue of approximately $34 million and GTV3 of more than $7 billion in the trailing twelve month period ending December 31st, 2020. Lightspeed will acquire Vend for total estimated consideration of approximately $350 million, satisfied by way of payment on closing of approximately $192.5 million in cash and the issuance of subordinate voting shares in the capital of Lightspeed valued at approximately $157.5 million. The deal, which is subject to customary closing conditions and post-closing working capital adjustment, is expected to close towards the end of April, subject to the receipt of applicable regulatory approvals.”
As always - many thanks.
Clayton

Q: One of the "highlights" from Kinaxis' recent quarter was the decline in gross profit. From what I can tell, it seems that R&D spending was significantly higher, in part to augment AI capabilities. Can you shed any light on this decrease in profit and if it was from higher R&D is that not a good use of capital and does that not bode well for the company going forward?

Appreciate your insight.

Paul F.

Q: Hello Peter, Ryan, and Team,

Wondering if you think it's still worth putting some money into the re-opening trade via one of the airlines. I'm considering reducing my position in REAL in order to do so. Although REAL is relatively cheap right now, its price trend is still moving lower. I know you like Southwest Airlines, but Air Canada's share price is nowhere near pre-pandemic levels, while LUV is already there. I have been reluctant to invest in the airlines, as I'm convinced that business travel will never return to the same levels. Many companies have finally realized it's often unnecessary and that cost-effective, technology-based alternatives are preferred. However, I think the pent-up leisure travel demand will likely make up for this on a short-term basis. Can I please have your thoughts?
Thank you.
Brad

Q: Any reason why EGLX is crashing, other that I bought it?

Q: So working in the finance industry, when it comes to business valuation, I know private health clinics get very low multiples. If Well is continues to consolidate in a space where now one else is and provides technological efficiencies. Even if they are just able to capture the majority of market share in Canada, could the potential upside be the sky?

Q: Please comment on earnings

Q: Hi
Reading into your answer a while back that TOI could be compared as a mini CSU. Could one assume then that TOI has a better growth potential long term?
I'm considering switching my CSU shares over to TOI.
Thanks
Jeff

Q: Further to Arnold’s question of March 9th. Enbridge’s stock is holding in quite well? Is this likely a result that investors believe there is a significant likelihood a positive resolution or compromise will be reached regarding Line 5? What is your best guess? Thanks.

Q: I have a 4% position in Air Canada. I've made over 30% so far. I think it still has room to run as the economy opens up, but who knows. At what point would you start to lighten up?

Jason

Q: I am a buy and hold investor. For an unregistered account which of the above would you recommend and why?

Ron

Q: Hi,
TFII is the only stock in the BE portfolio that I don't own, but I do own MU. Should I sell MU to buy TFII, or should I stick with MU.
Thanks

Q: on Tuesday priced an underwritten marketed public offering of about 9.1 million of its common shares in the US and Canada at $27.50 per share.... how will this affect current stock price

Q: Hi 5i team,
This is not a question. Regarding the book value of TOI , it's best to confirm with CSU. Apparently, the book value for the stock distribution is indeed close to zero per CSU client relation.

Q: Good day
Photon Control has been around since 1988. With this amount of experience and some capital does the company have the capacity to reach new highs even though the Canadian Dollar is gaining? Thank folks

Q: Will you please give us your thoughts on Alaris's 1/4, and your thoughts about it's future.

Thanks

Q: Hi there,

I only have a little bit of money to put in right now and I’m looking at either WELL or Air Canada - which would you recommend? I am comfortable holding for a year or two minimum and am looking for growth but want to stay on the safer side. Appreciate your insight!

Q: Is there a comparable company in the US to DND? It would seem like a great market for the company.
Thank You, Peter

Q: Air Canada seems to be getting more and more into the cargo shipment segment. How material is this segment of the business currently and do you see it becoming a new growth area?

Q: I have a loss over 22% in DND in my non registered account. Would it make sense to high grade to one of the other three given current sell off in all four stocks? Which one would provide the best long term growth?
Thank you